30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Arthrosurface Gains FDA Clearance for OVOMotion Stemless Total Shoulder -

Arthrosurface received FDA 510(k) clearance to market OVOMotion™, a stemless total shoulder arthroplasty system to treat damage from arthritis, trauma or Avascular Necrosis. The design combines anatomic restoration with aspherical head, and is cleared for use with the company's Inlay Glenoid system. Studies have shown that the non-spherical head optimizes the shoulder's natural movement, while the inlay glenoid showed no loosening at 4,000 cycles vs. onlay designs, which were clinically loose after ~1,100 cycles. (Arthrosurface, Inc., 4/18/18)